drugset / Trial / NCT05952219

Study to Evaluate the Safety and Pharmacokinetics of CKD-379

NCT05952219

Phase 1 Unknown 32 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A study to compare the pharmacokinetics and safety between CKD-379 and D759, D745, D029, D150 combination

Timeline

Start
2023-06-02
Primary completion
2023-06-19
Completion
2023-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-379 Unknown
Subject D029 Unknown
Subject D150 Unknown
Subject D745 Unknown
Subject D759 Unknown